TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction

Cardiovasc Res. 2017 Jan;113(1):15-29. doi: 10.1093/cvr/cvw218. Epub 2016 Oct 13.

Abstract

Aims: Thrombospondin-1 (TSP1) is a ligand for CD47 and TSP1-/- mice are protected from pulmonary hypertension (PH). We hypothesized the TSP1-CD47 axis is upregulated in human PH and promotes pulmonary arterial vasculopathy.

Methods and results: We analyzed the molecular signature and functional response of lung tissue and distal pulmonary arteries (PAs) from individuals with (n = 23) and without (n = 16) PH. Compared with controls, lungs and distal PAs from PH patients showed induction of TSP1-CD47 and endothelin-1/endothelin A receptor (ET-1/ETA) protein and mRNA. In control PAs, treatment with exogenous TSP1 inhibited vasodilation and potentiated vasoconstriction to ET-1. Treatment of diseased PAs from PH patients with a CD47 blocking antibody improved sensitivity to vasodilators. Hypoxic wild type (WT) mice developed PH and displayed upregulation of pulmonary TSP1, CD47, and ET-1/ETA concurrent with down regulation of the transcription factor cell homolog of the v-myc oncogene (cMyc). In contrast, PH was attenuated in hypoxic CD47-/- mice while pulmonary TSP1 and ET-1/ETA were unchanged and cMyc was overexpressed. In CD47-/- pulmonary endothelial cells cMyc was increased and ET-1 decreased. In CD47+/+ cells, forced induction of cMyc suppressed ET-1 transcript, whereas suppression of cMyc increased ET-1 signaling. Furthermore, disrupting TSP1-CD47 signaling in pulmonary smooth muscle cells abrogated ET-1-stimulated hypertrophy. Finally, a CD47 antibody given 2 weeks after monocrotaline challenge in rats upregulated pulmonary cMyc and improved aberrations in PH-associated cardiopulmonary parameters.

Conclusions: In pre-clinical models of PH CD47 targets cMyc to increase ET-1 signaling. In clinical PH TSP1-CD47 is upregulated, and in both, contributes to pulmonary arterial vasculopathy and dysfunction.

Keywords: CD47; Clinical pulmonary hypertension; ET-1; Thrombospondin-1; cMyc.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Arterial Pressure*
  • CD47 Antigen / genetics
  • CD47 Antigen / metabolism*
  • Case-Control Studies
  • Cell Line
  • Disease Models, Animal
  • Endothelial Cells / metabolism
  • Endothelin-1 / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / physiopathology
  • Hypertension, Pulmonary / prevention & control
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Middle Aged
  • Phenotype
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • Pulmonary Artery / metabolism*
  • Pulmonary Artery / physiopathology
  • RNA Interference
  • Rats
  • Signal Transduction*
  • Thrombospondin 1 / deficiency
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism*
  • Transfection
  • Up-Regulation
  • Vasoconstriction
  • Vasodilation
  • Young Adult

Substances

  • CD47 Antigen
  • CD47 protein, human
  • Cd47 protein, mouse
  • Endothelin-1
  • MYC protein, human
  • Myc protein, mouse
  • Proto-Oncogene Proteins c-myc
  • Thrombospondin 1
  • thrombospondin-1, human
  • Thbs1 protein, mouse